文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

更正：一种靶向腺苷A2A受体的抗帕金森病药物增强了淀粉样β蛋白的生成和γ-分泌酶活性。

Correction: An Anti-Parkinson's Disease Drug via Targeting Adenosine A2A Receptor Enhances Amyloid-β Generation and γ-Secretase Activity.

出版信息

PLoS One. 2017 Feb 16;12(2):e0172775. doi: 10.1371/journal.pone.0172775. eCollection 2017.

DOI:10.1371/journal.pone.0172775
PMID:28207857
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5313219/
Abstract

[This corrects the article DOI: 10.1371/journal.pone.0166415.].

摘要

[本文更正了文章的数字对象标识符：10.1371/journal.pone.0166415。]

相似文献

[1]
Correction: An Anti-Parkinson's Disease Drug via Targeting Adenosine A2A Receptor Enhances Amyloid-β Generation and γ-Secretase Activity.

PLoS One. 2017-2-16

[2]
An Anti-Parkinson's Disease Drug via Targeting Adenosine A2A Receptor Enhances Amyloid-β Generation and γ-Secretase Activity.

PLoS One. 2016-11-11

[3]
Correction: Gamma-Secretase-Dependent and -Independent Effects of Presenilin1 on β-Catenin·Tcf-4 Transcriptional Activity.

PLoS One. 2016-8-15

[4]
Increased adenosine A2A receptors in the brain of Parkinson's disease patients with dyskinesias.

Brain. 2004-5

[5]
Correction: NF-κB is activated in CD4+ iNKT cells by sickle cell disease and mediates rapid induction of adenosine A2A receptors.

PLoS One. 2015-2-6

[6]
JNJ-40255293, a novel adenosine A2A/A1 antagonist with efficacy in preclinical models of Parkinson's disease.

ACS Chem Neurosci. 2014-9-24

[7]
Correction: Exploring the reproducibility of functional connectivity alterations in Parkinson's disease.

PLoS One. 2018-5-3

[8]
[The treatment of Parkinson's disease--adenosine A2A receptor antagonists].

Nihon Rinsho. 2002-1

[9]
Correction: Long-Latency Somatosensory Evoked Potentials of the Subthalamic Nucleus in Patients with Parkinson's Disease.

PLoS One. 2017-4-6

[10]
Mode of action of adenosine A2A receptor antagonists as symptomatic treatment for Parkinson's disease.

Int Rev Neurobiol. 2014

本文引用的文献

[1]
An Anti-Parkinson's Disease Drug via Targeting Adenosine A2A Receptor Enhances Amyloid-β Generation and γ-Secretase Activity.

PLoS One. 2016-11-11

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索